Your session is about to expire
← Back to Search
Digital Program for Cognitive Impairment
N/A
Recruiting
Led By Deborah Barnes, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 3 months
Awards & highlights
Study Summary
This trial will develop and test a program to help older adults with cognitive decline improve their brain health.
Who is the study for?
This trial is for older adults in the U.S. with mild cognitive impairment or subjective cognitive decline, ready to improve brain health. They must have internet access, a device with a camera, speak English, and be willing to make lifestyle changes. Excluded are those with severe impairments, recent major health events, other conflicting studies participation or certain neurological/psychiatric conditions.Check my eligibility
What is being tested?
The Brain Health Together program aims to support brain health in older adults through live-streaming group sessions focused on lifestyle changes. The study will evaluate how effective this digital intervention is at maintaining or improving cognitive function among participants.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like education and lifestyle modifications rather than drugs or medical procedures, traditional side effects are not expected; however, participants may experience fatigue or stress from new activities.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Alzheimer's Disease Risk Index - Short Form-Change (ANU-ADRI-SF)
Maintain Your Brain Online Cognitive Test Battery-Change
Secondary outcome measures
Alcohol-Change
Cognitive activity-Change
Depression-Change
+10 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: Maintain Brain Health TogetherExperimental Treatment1 Intervention
Participants in this arm will participate in the full Brain Health Together program for 12 weeks (30 hours) followed by weekly group classes and six 1-on-1 coaching sessions for another 12 weeks (additional 15 hours; 45 hours total)
Group II: Brain Health TogetherExperimental Treatment1 Intervention
Participants in this arm will participate in online, live-streaming Moving Together classes (1 hour a week) and group brain health classes (1 hour a week) and will work 1-on-1 with a brain health coach to set personalized risk reduction goals (0.5 hours a week) for 12 weeks (30 hours total)
Group III: Brain Health AcademyExperimental Treatment1 Intervention
Participant in this arm will watch expert videos on a wide range of brain health topics and will complete quizzes for 2.5 hours a week for 12 weeks (30 hours total)
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,236,255 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,848 Total Patients Enrolled
Deborah Barnes, PhDPrincipal InvestigatorPrimary Investigator
2 Previous Clinical Trials
4,772 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with Alzheimer's disease or dementia.I do not have a major neurological disorder like Parkinson's, MS, or ALS.My mood or anxiety disorder has been difficult to manage lately.I have had a spinal fracture in the last year.I have noticed a decline in my memory or thinking, or I was diagnosed with mild cognitive impairment in the last year.I have not had a stroke or heart attack in the last year.I can move around without needing help or devices.I have two or more risk factors for brain health issues.I can join live online classes with video.I have experienced severe dizziness or vertigo in the last year.I do not have severe vision or hearing problems.
Research Study Groups:
This trial has the following groups:- Group 1: Brain Health Academy
- Group 2: Brain Health Together
- Group 3: Maintain Brain Health Together
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do I comply with the requirements to enter this research project?
"In order to meet the criterion for this medical study, applicants must have mild cognitive impairment and be between 55-85 years of age. Currently, a total of 216 participants are needed."
Answered by AI
Is participation in this medical experiment open to seniors who are more than seventy years old?
"As listed in the eligibility criteria, applicants for this trial must fall between 55 and 85 years old. Additionally, there are 25 trials available for patients younger than 18 and 563 specifically tailored to those above 65."
Answered by AI
Are any individuals being enlisted for this investigation at the present moment?
"The records on clinicaltrials.gov indicate that, as of this writing, the recruitment process for this specific medical study is closed. This trial was posted in April 10th 2023 and last updated 5 days later; however, 602 alternative studies are still actively welcoming patients."
Answered by AI
What key objectives should this clinical trial seek to achieve?
"This trial seeks to measure the Alzheimer's disease Risk Index - Short Form-Change (ANU-ADRI-SF) over a baseline and 3 month period. Secondary outcomes include changes in Depression, Loneliness / Social Isolation, and Emotional Wellbeing as measured by respective validated scales. Results for these metrics range from -94 to +94, 3 to 9, and 9 to 45 respectively with higher scores indicating more favourable results."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger